Quantbot Technologies’s Cytosorbents CTSO Stock Holding History
Bought
Maintained
Sold
Other funds holding CTSO
Quantbot Technologies's CTSO Position: Q4 2021 in Review
Quantbot Technologies sold out of Cytosorbents (CTSO) in Q4 2021, closing a stake of 210 shares — an estimated $34K sold.
Quantbot Technologies first reported a position in CTSO in Q2 2020 and held it in 3 quarters. The position peaked at $34K in Q3 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.
- Quantbot Technologies reported no remaining Cytosorbents position as of Q4 2021 after selling out during the quarter.
- Quantbot Technologies sold 210 Cytosorbents shares in Q4 2021, an estimated $34K.
- Quantbot Technologies first reported a position in Cytosorbents in Q2 2020 and held it in 3 quarters.
- Quantbot Technologies's Cytosorbents position peaked at $34K in Q3 2021.
- 91 funds tracked by Wall St. Rank held Cytosorbents as of Q4 2021.
Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.